CPSA USA 2015

Getting Medicines to Patients Faster by Eliminating the Bottlenecks in Drug Discovery and Development

The Distinguished Lecture Series

Each year, The Distinguished Lecture Series welcomes innovative and cutting edge lecturers to encourage discussion, exchange of ideas as well as collaboration.

The Distinguished Lecture Series event takes place Monday evening

 

Douglas Lewis

CPSA 2015 Distinguised Lecturer

Douglas Lewis
President and Scientific Director
United States Drug Testing Laboratories, Inc.

Fetal Alcohol Exposure - A 30 Year Search for a Reliable Biomarker



Douglas Lewis is the founder, president and scientific director of United States Drug Testing Laboratories, Inc. (USDTL) where he oversees development of new matrices for use in diagnosing substances of abuse, such as: umbilical cord tissue used to determine substance exposure in newborns, and fingernails to determine alcohol biomarkers and substances of abuse.

Lewis’s research record includes co-principal investigator on a $6.57 million NIDA funded grant entitled "Prenatal Methamphetamine Exposure and Child Outcome," co-investigator on three Small Business Innovation Research (SBIR) Phase I grants—“Diagnostic Viability of Umbilical Cord Specimens,” “Using Human Hair to Determine Long Term Alcohol Abuse” and Hair Ethyl Glucuronide as a Long-Term Alcohol Biomarker”—and co-investigator on an SBIR Phase II grant “Diagnostic Viability of Umbilical Cord Specimens.

Prior to USDTL, he spent five years in academia as an assistant professor of clinical pathology at Northwestern University Medical School while also serving as the head of the toxicology section at the Children’s Memorial Hospital in Chicago. During his tenure at Northwestern and Children’s, Lewis established the first non-Olympic anabolic steroids testing laboratory in the United States and was a toxicologist for the U.S. Weight Lifting Federation

 

Distinguished Lecturers Past

2014

Steven Wong, Wake Forest University
Translational Mass Spectrometry Enabling Personalized Medicines

2013

Richard Kibbey, Yale University
Mitochondrial GTP Cycle: A Novel Metabolic Pathway Regulating Glucose Homeostasis